Sign in to view content

Safety of Intravitreal Pegcetacoplan for Geographic Atrophy: 12-Month Results of the OAKS and DERBY Trials

Caroline Baumal, MD

Video
Published 2022

Related

Safety and Efficacy of SC Elamipretide to Treat Noncentral Geographic Atrophy: ReCLAIM-1 Results and Phase II ReCLAIM-2 Baseline Characteristics
David R Lally, MD
Annual Meeting Talks
2021
Efficacy of Intravitreal Pegcetacoplan in Geographic Atrophy: Results from the Phase 3 DERBY and OAKS Trials
Nathan C. Steinle, MD
Updates from the Field
2021
Visual Acuity and Reading With One Eye Versus Both Eyes Open in Geographic Atrophy and Associations With Patient-Reported Vision-Related Function
Jun Kong, MD, PhD
On Demand Cases, Courses, and Papers
2021

Category: AMD-Non-Neovascular

See more